COST PER RESPONDER OF BIMEKIZUMAB AGAINST IL17A, IL-12/23 AND IL-23 INHIBITORS IN THE TREATMENT OF PSORIATIC ARTHRITIS IN SWEDEN

被引:0
|
作者
Lyris, N. [1 ]
Geale, K. [2 ,3 ]
Aldven, M. [3 ]
Engstrom, A. [4 ]
Willems, D. [5 ]
机构
[1] UCB Pharma, Slough, Berks, England
[2] Umea Univ, Dept Publ Hlth & Clin Med, Dermatol & Venerol, Umea, Sweden
[3] Quantify Res, Stockholm, Sweden
[4] UCB Pharm, Stockholm, Sweden
[5] UCB Pharm, Brussels, Belgium
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE649
引用
收藏
页码:S178 / S178
页数:1
相关论文
共 50 条
  • [1] COST-PER-RESPONDER ANALYSIS OF BIMEKIZUMAB (IL17A/F INHIBITOR) AGAINST IL-17A, IL-12/23 AND IL-23 INHIBITORS FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN FINLAND
    Veijalainen, L.
    Lyris, N.
    Elo, P. J. K.
    Ferguson, A.
    Willems, D.
    VALUE IN HEALTH, 2024, 27 (12)
  • [2] The role of IL-23 and the use IL-23 inhibitors in psoriatic arthritis
    Fragoulis, George E.
    Siebert, Stefan
    MUSCULOSKELETAL CARE, 2022, 20 : S12 - S21
  • [3] Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis A Case Series
    Shurey, Megan
    Yip, Ashley
    Ziouzina, Olga
    Chan, Jonathan
    Dutz, Jan P.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E626 - E628
  • [4] IL-23 inhibitors for psoriatic arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2022, 4 (01): : E20 - E20
  • [5] The IL-23/IL-17 axis in psoriatic arthritis
    Suzuki, Erika
    Mellins, Elizabeth D.
    Gershwin, M. Eric
    Nestle, Frank O.
    Adamopoulos, Iannis E.
    AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) : 496 - 502
  • [6] COST PER RESPONDER ASSOCIATED WITH BIMEKIZUMAB AGAINST IL-17A-INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN SWEDEN
    Morup, M.
    Geale, K.
    Ferguson, A.
    Engstrom, A.
    Willems, D.
    VALUE IN HEALTH, 2023, 26 (12) : S117 - S117
  • [7] COST-PER-RESPONDER ANALYSIS OF BIMEKIZUMAB (IL-17A/F INHIBITOR) AGAINST IL-23 TARGETED THERAPIES FOR PSORIATIC ARTHRITIS IN SPAIN, BASED ON MATCHING-ADJUSTED INDIRECT COMPARISONS
    Mestre-Ferrandiz, J.
    Navarro-Compan, V
    Ivanova, Y.
    Gonzalez-Dominguez, A.
    Maratia, S.
    VALUE IN HEALTH, 2024, 27 (12) : S119 - S119
  • [8] IL-12/IL-23 inhibitors: a promising approach to the treatment of inflammatory disorders
    Wada, Yumiko
    DRUGS OF THE FUTURE, 2008, 33 (01) : 49 - 63
  • [9] IL-23 inhibition for the treatment of psoriatic arthritis
    Mohanakrishnan, Raagav
    Beier, Secia
    Deodhar, Atul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (01) : 59 - 65
  • [10] Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis
    Alunno, Alessia
    Carubbi, Francesco
    Cafaro, Giacomo
    Pucci, Giacomo
    Battista, Francesca
    Bartoloni, Elena
    Giacomelli, Roberto
    Schillaci, Giuseppe
    Gerli, Roberto
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1727 - 1737